EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor

NF-κB signaling in inflammation

Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text

Life Sciences, Immunology, Pathology +17

A guiding map for inflammation

Mihai G. Netea, Frances R. Balkwill, Michel Chonchol et al. · Nature Immunology · 2017 · 823 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Hui‐Wen Lo, Sheng-Chieh Hsu, Mohamed Ali‐Seyed et al. · Cancer Cell · 2005 · 538 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase

William M. Moore, R. Keith Webber, Gina Jerome et al. · Journal of Medicinal Chemistry · 1994 · 461 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 279 citations · Full text

Medicine, Cancer Biology, Oncology +17